Mifepristone manufacturer GenBioPro drops legal challenge to Mississippi ban
New Delhi: A manufacturer of mifepristone, a drug used in medication abortions, on Thursday dropped its legal fight to sell the drug in Mississippi after the state banned nearly all abortions.
GenBioPro Inc said it was voluntarily dismissing its lawsuit in a filing in federal court in Jackson. The company had argued that federal regulators' approval of mifepristone to induce abortion at up to 10 weeks of pregnancy overrode the state's prohibition on nearly all abortions.
"Given the changed national landscape, we have decided to adjust our strategy and withdraw our existing case in Mississippi," the company said in a statement. "We are committed to using the law to remove unnecessary barriers for patients and providers and we look forward to making an announcement soon about our next steps."
"We are pleased to have again successfully defended Mississippi's abortion laws," Mississippi Attorney General Lynn Fitch said in a statement.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.